KMID : 1101720210250020001
|
|
Physical Activity and Nutrition 2021 Volume.25 No. 2 p.1 ~ p.7
|
|
Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review
|
|
Hong Bok-Sil
Kim Myoung-Ryu
|
|
Abstract
|
|
|
Purpose: Recent studies have shown that COVID-19 is often associated with altered gut microbiota composition and reflects disease severity. Furthermore, various reports suggest that the interaction between COVID-19 and host-microbiota homeostasis is mediated through the modulation of microRNAs (miRNAs). Thus, in this review, we aim to summarize the association between human microbiota and miRNAs in COVID-19 pathogenesis.
Methods: We searched for the existing literature using the keywords such ¡°COVID-19 or microbiota,¡± ¡°microbiota or microRNA,¡± and ¡°COVID-19 or probiotics¡± in PubMed until March 31, 2021. Subsequently, we thoroughly reviewed the articles related to microbiota and miRNAs in COVID-19 to generate a comprehensive picture depicting the association between human microbiota and microRNAs in the pathogenesis of COVID-19.
Results: There exists strong experimental evidence suggesting that the composition and diversity of human microbiota are altered in COVID-19 patients, implicating a bidirectional association between the respiratory and gastrointestinal tracts. In addition, SARS-CoV-2 encoded miRNAs and host cellular microRNAs modulated by human microbiota can interfere with viral replication and regulate host gene expression involved in the initiation and progression of COVID-19. These findings suggest that the manipulation of human microbiota with probiotics may play a significant role against SARS-CoV-2 infection by enhancing the host immune system and lowering the inflammatory status.
Conclusion: The human microbiota-miRNA axis can be used as a therapeutic approach for COVID-19. Hence, further studies are needed to investigate the exact molecular mechanisms underlying the regulation of miRNA expression in human microbiota and how these miRNA profiles mediate viral infection through host-microbe interactions.
|
|
KEYWORD
|
|
SARS-CoV-2, COVID-19, human microbiota, dysbiosis, gut-lung axis, microRNAs
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|